LSPediA Releases VRS Solution for DSCSA Saleable Returns

Farmington Hills, MI – January 29, 2019 – LSPediA LLC, a leading SaaS solution provider for the pharmaceutical industry, today announced the General Available release of VRS software Saleable® after completing multiple successful deployments for Early adopter customers.

This brand-new Verification Router Service allows wholesaler distributors to tap into the $11 billion market for returned saleable drugs. The new Saleable® software solution from LSPEDIA not only verifies serialized products with a single scan of the 2D barcode but also is fully compliant with the new GS1 messaging standard released just weeks ago.

“Our research has shown that the single biggest reason for returned pharmaceuticals is the simple problem of overstocking at dispensaries,” explained LSPedia CEO and founder Riya Cao. “That’s more than $11 billion of saleable drugs each year that can go back out to patients – but only if those drug products can be verified under the new FDA DSCSA requirement. Our VRS solution Saleable® completes verification in sub-second performance, works every minute of every day, and handles the entire process with a single scan.”

Saleable® comes out just in time to help wholesale distributors and manufacturers meet the FDA’s November deadline for complying with new DSCSA rules for handling saleable returns.

“With just 10 months to go, distributors and manufacturers can plug Saleable® into their operations and meet all the new requirements with no fears,” Ms. Cao added.

Saleable® is a completely comprehensive Industry 4.0 Verification Router Service that serves as a platform, a network, and an application.  With one swipe of any 2D barcode, Saleable® routes verification requests to the manufacturer’s EPCIS serial repository for an immediate query and response, offering a sub-second response time for each transaction.

Saleable® consolidates all Lookup Directory information, synchronizing that data daily in real time, and works with both warehouse systems and through LSPediA’s new web application. Saleable® also provides audit trails for any specific transaction and allows users to sort and group the history data and export it for analytics.

Beyond maximizing the potential revenue of saleable returns, Saleable® quickly and easily identifies expired, short-dated, damaged, or recalled products that can pose dangerous risks to patients and liability for any company that doesn’t install a trustworthy solution to sort out saleable from non-saleable drugs.

Offering full VRS capabilities, Saleable® has quickly become the preferred platform for verifying returns among trading partner in the US and globally. Nearly 40 percent of manufacturers told LSPediA that they prefer VRS technology and won’t even offer EPCIS data to their customers. And two-thirds of trading partners report that they will be adding VRS verification technology or already have done so.

To find out about all the many benefits of VRS technology offered by Saleable®, book a demonstration with LSPEDIA now.

About LSPediA

LSPediA is a leading supply chain software provider for the pharmaceutical industry. LSPediA’s serialization solution RxChain®, RxChain™ Mobile, and Saleable® protect pharma companies against regulatory risks and improves supply chain efficiency. Pharmaceutical manufacturers, wholesale distributors, dispensers, and healthcare providers partner with LSPediA to manage serial data, distribute serialized drug products, verify the validity of the drug product. To learn more, please call (248) 973-2008, email info@lspedia.com, or visit www.lspedia.com.